Valeo Financial Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Valeo Financial Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,032	Closed	-$1K	–	1827
2018 Q1	$1K	Hold	2,032	–	–	﹤0.01%	1520
2017 Q4	$3K	Hold	2,032	–	–	﹤0.01%	1153
2017 Q3	$3K	Buy	+2,032	New	+$2.89K	﹤0.01%	992

Other funds holding ANTH

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Valeo Financial Advisors's ANTH Position: Q2 2018 in Review

Valeo Financial Advisors sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 2,032 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in ANTH in Q3 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

Valeo Financial Advisors reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Valeo Financial Advisors sold 2,032 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
Valeo Financial Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2017 and held it in 3 quarters.
Valeo Financial Advisors's Anthera Pharmaceuticals, Inc. position peaked at $3K in Q4 2017.
5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Valeo Financial Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.